Log in to save to my catalogue

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular o...

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e3909f1acd08445bb4da02860f6072a0

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both

About this item

Full title

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-12, Vol.13 (1), p.21390-21390, Article 21390

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A critical feature of the VSV vector platform is the ability to pseudotype the virus with different glycoproteins from other viruses, thus altering cellular tropism of the recombinant virus. The route of administration is critical in triggering local and systemic immune response and protection. Most of the vaccine platforms used at the forefront ar...

Alternative Titles

Full title

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e3909f1acd08445bb4da02860f6072a0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e3909f1acd08445bb4da02860f6072a0

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-48397-7

How to access this item